
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synthomer Plc | LSE:SYNT | London | Ordinary Share | GB00BNTVWJ75 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.60 | -0.88% | 180.90 | 181.00 | 184.90 | 183.90 | 174.70 | 182.50 | 319,925 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 2.59B | -32.5M | -0.1987 | -9.11 | 296.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/1/2022 19:06 | I agree with your thinking. | ![]() james dean | |
11/1/2022 18:46 | Well, I'm in now. Think we'll see a little bounce on the trading update followed by a rise back to the old trend line | ![]() hatfullofsky | |
17/12/2021 09:58 | PIWORLD interview with Richard Leonard: Winners and Losers of 2021 02:24 What went badly: Synthoma #SYNT Video: | ![]() tomps2 | |
07/12/2021 11:50 | Predictable bounce today but still much further to go. | ![]() deadly | |
07/12/2021 07:57 | https://www.fool.co. | tole | |
06/12/2021 14:28 | MS clients obviously didn't get as many shares as they wanted. | ![]() podgyted | |
06/12/2021 14:01 | Institutional Placing at 485p just over a month ago? | ![]() libertine | |
06/12/2021 10:04 | I suppose looking at the one year chart you could say with hindsight that a pull back to around 433p was inevitable. Probably next year there is going to be the oversupply of nitrile that was threatened pre-Covid. The whole point of the Eastman acquisition though is to dilute the effect of the end of the nitrile superprofits. I can see potential for bumpier trading conditions next year but I think SYNT remains a great long-term investment. | ![]() kinwah | |
06/12/2021 09:51 | Just bought - MS say 400p today, Canacorrd said 750p last week. Happy to go in at 433. | ![]() chris79 | |
06/12/2021 09:47 | Double downgrade on non-specific news seems a little opportunistic to me. Wouldn't be surprised to see massive buying later once they got it down to their target price. Hound Partners also probably looking to fully close their short position which is now below 0.5%. | ![]() ppreston1 | |
06/12/2021 09:18 | Morgan Stanley double downgrade this morning price target 400p | ![]() libertine | |
06/12/2021 09:16 | No significant movement elsewhere in the sector, if anything they are mostly up today. I have noted the lack of a q3 trading update, was one in October last year | ![]() texaspete2 | |
06/12/2021 09:11 | Morgan Stanley cut to underweight could be responsible. | ![]() clanger66 | |
06/12/2021 09:07 | No idea. Anyone in this sector reporting? | ![]() kevph | |
06/12/2021 09:07 | After wording past week with gdr rns on when next news on new fast covid test expect more blue . | ![]() capitol2 | |
06/12/2021 08:47 | Why the 9% fall? Can find nothing, no RNS. | ![]() madjak | |
15/11/2021 09:23 | Thanks podgyted. Agreed not much substance to that trading update. I guess will have to do for now. | ![]() ppreston1 | |
13/11/2021 15:38 | Don't think we're going to get a separate one - in October for last 2 years. This was included in the October acquisition RNS:- "5. Current Trading Update Since Synthomer's reported Interim Results on 5th August 2021, underlying demand has remained strong in line with management expectations · The Movement Control Order in Malaysia was implemented to restrict the impact of COVID-19, leading to reduced customer utilisation and demand. · Action to offset raw material inflation coupled with the continued benefits from OMNOVA, investment in new capacity and ongoing efficiency measures has underpinned performance. · Consequently, Synthomer's outlook for the full year remains unchanged with FY 2021 EBITDA expected to be in excess of £500m. Looking ahead, the Group continues to expect Performance Elastomers to normalise in Q1 2022 as the impact of the COVID-19 pandemic reduces and incremental market capacity comes online. The Board is confident that the business model provides differentiation and increasing specialisation and the Group's strong balance sheet is expected to support continued inorganic and organic growth in due course." Bit short on detail, but I guess that's yer update. | ![]() podgyted | |
11/11/2021 08:31 | Anyone know when the Q3 trading update is due? Thanks. | ![]() ppreston1 | |
04/11/2021 18:45 | Another good day for the wife when her dividend arrived this morning. | ![]() james dean | |
29/10/2021 14:50 | Interactive investors winter list, Lio, Safe, Xpp, Hlma, Adm, Synt, SXs, Hils, It’s performed very well over the last 8 winters | ![]() nerja | |
28/10/2021 10:45 | I recently bought in here. I thought it looked very solid and far too cheap on any measure. The chart appeared to read oversold to me too. The market obviously likes the aquisition despite the fundraising. | ![]() thorpematt | |
28/10/2021 09:31 | Historically SYNT's acquisitions have always provided a boost to earnings in the medium term. The timing looks good as the nitrile super profits will be coming to an end fairly soon. I can see the shares hitting £6 some time next year. | ![]() kinwah | |
28/10/2021 07:17 | Acquisition Share Placing | ![]() madjak |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |